Head of Section: Professor Clive E Adams

The Cochrane Schizophrenia Group is concerned with the evaluation of the prevention, treatment and rehabilitation of people with non-affective, functional, psychotic illnesses.

The work of the group concentrates on three main areas. The first is the preparation, publication and maintenance of systematic reviews of the effects of interventions for schizophrenia. These reviews are published quarterly on the Cochrane Library, and are updated periodically to incorporate new research as it becomes available on the dedicated website http://szg.cochrane.org/en/index.html 

The second is the development and maintenance of a specialised register of trials relevant to the scope of the group’s work and this has been a fruitful area of original research.

The third area of work is undertaking real-world randomised trials. Large high quality studies have been carried out in Brazil, India and the UK. The Group is now working with partners in Finland, Brazil and the UK designing randomised studies that are truly relevant to everyday care.

The editorial base is located within the Institute but the editors are based around the world. The Group works with 500 active reviewers in 21 different countries to ensure high standards and spread the learning.

If you would like further information on this section, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it , Managing Editor.